Business
Crescent Capital BDC, Inc. Announces Public Offering of Common Stock
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or the “Company”) (NASDAQ: CCAP) today announced that it has
About this update from Crescent Capital Bdc, Inc.
[{"type":"text","content":"LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or the “Company”) (NASDAQ: CCAP) today announced that it has commenced an underwritten primary offering of 2,500,000 shares of its common stock (the “Offering”). The Company also expects to grant the underwriters an option to purchase up to an additional 375,000 shares of its common stock to cover over-allotments, if any. The Offering will be made pursuant to the Company’s shelf-registration statement, which was filed with and declared effective by the Securities and Exchange Commission (the “Commission”). The Company’s investment adviser, Crescent Cap Advisors, LLC (the “Adviser”), has agreed to pay the underwriters a supplemental payment, which will reflect the difference between the actual public offering price and the net proceeds to be received by Crescent BDC in this offering. In addition, the Adviser has agreed to bear the sales load payable to the underwriters. The Company is not obligated to repay the supplemental payment and sales load paid by the Adviser. The Company intends to use the net proceeds from the Offering for general corporate purposes, which may include the repayment of outstanding indebtedness and investing in portfolio companies in accordance with its investment objective and strategies. BofA Securities, Wells Fargo Securities, LLC, Morgan Stanley & Co. LLC, Keefe, Bruyette & Woods, A Stifel Company and RBC Capital Markets, LLC are serving as joint book-running managers for the Offering. Oppenheimer & Co. Inc. and SMBC Nikko Securities America, Inc. are serving as co-managers for the Offering. Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing. The preliminary prospectus supplement, dated November 15, 2021, and the accompanying prospectus, dated August 6, 2021, which have been filed with the Commission, contain this and other information about the Company and should be read carefully before investing. The information in the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may be changed. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the shares referred to in this press release in any state or jurisdic...